A single Clostridium difficile infection presents an array of challenges for hospitals. A December 2015 study in the American Journal of Infection Control found C. difficile infections can increase ...
Roche Holdings AGRHHBY recently launched CE-IVD - the cobas MRSA/SA nucleic acid test. The test will be used on the cobas Liat System for the qualitative detection and differentiation of ...
The FDA approvals of Roche Holdings' RHHBY Hemlibra or Cobas Cdiff Nucleic acid test and Thermo Fisher Scientific's TMO slew of advancements in next-generation sequencing (the latest one being the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results